Dermal fillers are injectable medical devices used to restore volume, enhance contour, improve symmetry, and support structural rejuvenation of the face and body. The most commonly used fillers in aesthetic practice are hyaluronic acid (HA)-based products. Treatment areas may include facial regions (lips, cheeks, jawline, chin, tear trough, temples, hands) and body contouring areas (hips, buttocks, and other volume-deficient regions).

Dermal fillers may not be suitable if you: • Are pregnant or breastfeeding • Have an active skin infection near the treatment area • Have uncontrolled autoimmune conditions • Have a history of severe allergic reactions (anaphylaxis) • Are currently unwell or immunocompromised • Are taking certain anticoagulant medications • Have unrealistic expectations regarding outcomes A full medical history and consultation will be conducted prior to treatment to assess suitability and identify any contraindications.

Common & Temporary Effects The following are expected and usually resolve without intervention: • Swelling • Bruising • Redness • Tenderness • Localised firmness • Temporary asymmetry Facial treatments typically settle within 3–14 days. Body treatments may require a longer settling period depending on the volume used and anatomical site. Infection Risk & Prevention Infection is uncommon but possible with any procedure that breaches the skin barrier. Risk reduction measures include: • Medical-grade skin preparation • Sterile, single-use equipment • Strict aseptic technique • Appropriate patient screening • Clear written aftercare instructions Patients must report increasing redness, warmth, pain, or discharge promptly. Less Common Risks • Prolonged swelling • Palpable or visible lumps • Product migration • Delayed inflammatory reactions • Reactivation of herpes simplex virus (in susceptible individuals) These are typically manageable following clinical review.

Risk mitigation strategies include: • Comprehensive consultation and consent process • Detailed anatomical assessment • Conservative treatment planning • Use of regulated, CE-marked products • Immediate access to complication management protocols • Structured follow-up pathways Use of Ultrasound Ultrasound imaging may be used where clinically appropriate to: • Visualise vascular structures • Assess tissue depth • Guide accurate filler placement • Evaluate previous filler • Assist in complication assessment Ultrasound provides real-time anatomical visualisation and may enhance safety in selected cases.

Informed consent requires that you: • Understand the nature of the procedure • Are aware of potential risks and side effects • Understand expected outcomes and limitations • Are informed of alternative options • Have the opportunity to ask questions • Provide voluntary written consent Treatment will only proceed once informed consent has been obtained.